AU2005212229B2 - Modafinil compositions - Google Patents
Modafinil compositions Download PDFInfo
- Publication number
- AU2005212229B2 AU2005212229B2 AU2005212229A AU2005212229A AU2005212229B2 AU 2005212229 B2 AU2005212229 B2 AU 2005212229B2 AU 2005212229 A AU2005212229 A AU 2005212229A AU 2005212229 A AU2005212229 A AU 2005212229A AU 2005212229 B2 AU2005212229 B2 AU 2005212229B2
- Authority
- AU
- Australia
- Prior art keywords
- modafinil
- percent
- degrees
- pxrd
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54275204P | 2004-02-06 | 2004-02-06 | |
| US60/542,752 | 2004-02-06 | ||
| US56041104P | 2004-04-06 | 2004-04-06 | |
| US60/560,411 | 2004-04-06 | ||
| US57341204P | 2004-05-21 | 2004-05-21 | |
| US60/573,412 | 2004-05-21 | ||
| US57917604P | 2004-06-12 | 2004-06-12 | |
| US60/579,176 | 2004-06-12 | ||
| US58199204P | 2004-06-22 | 2004-06-22 | |
| US60/581,992 | 2004-06-22 | ||
| US58675204P | 2004-07-09 | 2004-07-09 | |
| US60/586,752 | 2004-07-09 | ||
| US58823604P | 2004-07-15 | 2004-07-15 | |
| US60/588,236 | 2004-07-15 | ||
| AUPCT/US2004/029013 | 2004-09-04 | ||
| PCT/US2004/029013 WO2005023198A2 (en) | 2003-09-04 | 2004-09-04 | Modafinil compositions |
| US63178604P | 2004-11-30 | 2004-11-30 | |
| US60/631,786 | 2004-11-30 | ||
| PCT/US2005/002782 WO2005077894A1 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005212229A1 AU2005212229A1 (en) | 2005-08-25 |
| AU2005212229B2 true AU2005212229B2 (en) | 2011-06-09 |
Family
ID=38456572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005212229A Ceased AU2005212229B2 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1718607A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4917441B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005212229B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2556106A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA009949B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL176934A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005077894A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL163846A0 (en) | 2002-03-01 | 2005-12-18 | Univ South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| IL165383A0 (en) | 2002-06-21 | 2006-01-15 | Transform Pharmaceuticals Inc | Pharmaceutical compositions with improved dissolution |
| FR2849029B1 (fr) | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| WO2005099822A2 (en) * | 2004-04-13 | 2005-10-27 | Cephalon, Inc. | Reduction of drug / drug interactions with modafinil |
| EP1828098A1 (en) * | 2005-11-22 | 2007-09-05 | Teva Pharmaceutical Industries Ltd | Crystal forms of cinacalcet hci and processes for their preparation |
| CN100343228C (zh) * | 2006-02-17 | 2007-10-17 | 中国科学院上海有机化学研究所 | 高对映体选择性制备 2-二苯甲基亚磺酰基-乙酰胺单一对映体的方法 |
| EP1986994A2 (en) * | 2006-02-21 | 2008-11-05 | Teva Pharmaceutical Industries Ltd | Novel crystalline forms of armodafinil and preparation thereof |
| CA2688430A1 (en) * | 2007-06-04 | 2008-12-11 | Generics [Uk] Limited | Novel process |
| US7960586B2 (en) | 2007-08-16 | 2011-06-14 | Teva Pharmaceutical Industries Ltd. | Purification of armodafinil |
| US20090105346A1 (en) * | 2007-10-02 | 2009-04-23 | Alexandr Jegorov | Novel crystalline forms of armodafinil and preparation thereof |
| WO2009090663A1 (en) * | 2008-01-15 | 2009-07-23 | Lupin Limited | Novel crystalline polymorph of armodafinil and an improved process for preparation thereof |
| KR102126389B1 (ko) * | 2018-09-14 | 2020-06-25 | 셀라이온바이오메드 주식회사 | 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927855A (en) * | 1986-01-31 | 1990-05-22 | Laboratoire L. Lafon | Levorotatory isomer of benzhydrylsulfinyl derivatives |
| WO2002010125A1 (en) * | 2000-07-27 | 2002-02-07 | Teva Pharmaceutical Industries Ltd. | Crystalline and pure modafinil, and process of preparing the same |
| AU2003299349A1 (en) * | 2002-12-20 | 2004-07-29 | Neuraxpharm Pharmaceuticals S.L. | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2804322B1 (fr) * | 2000-01-31 | 2002-04-19 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies |
-
2005
- 2005-02-01 WO PCT/US2005/002782 patent/WO2005077894A1/en not_active Ceased
- 2005-02-01 CA CA002556106A patent/CA2556106A1/en not_active Abandoned
- 2005-02-01 AU AU2005212229A patent/AU2005212229B2/en not_active Ceased
- 2005-02-01 EP EP05712282A patent/EP1718607A4/en not_active Ceased
- 2005-02-01 JP JP2006552169A patent/JP4917441B2/ja not_active Expired - Fee Related
- 2005-02-01 EA EA200601390A patent/EA009949B1/ru not_active IP Right Cessation
-
2006
- 2006-07-18 IL IL176934A patent/IL176934A/en not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927855A (en) * | 1986-01-31 | 1990-05-22 | Laboratoire L. Lafon | Levorotatory isomer of benzhydrylsulfinyl derivatives |
| WO2002010125A1 (en) * | 2000-07-27 | 2002-02-07 | Teva Pharmaceutical Industries Ltd. | Crystalline and pure modafinil, and process of preparing the same |
| AU2003299349A1 (en) * | 2002-12-20 | 2004-07-29 | Neuraxpharm Pharmaceuticals S.L. | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007522147A (ja) | 2007-08-09 |
| EP1718607A4 (en) | 2008-05-28 |
| EP1718607A1 (en) | 2006-11-08 |
| EA009949B1 (ru) | 2008-04-28 |
| CA2556106A1 (en) | 2005-08-25 |
| IL176934A0 (en) | 2006-12-10 |
| EA200601390A1 (ru) | 2006-12-29 |
| WO2005077894A1 (en) | 2005-08-25 |
| IL176934A (en) | 2013-06-27 |
| JP4917441B2 (ja) | 2012-04-18 |
| AU2005212229A1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1608339B1 (en) | Pharmaceutical co-crystal of celecoxib-nicotinamide | |
| US8809586B2 (en) | Modafinil compositions | |
| CA2534664C (en) | Modafinil compositions | |
| EP1765379A2 (en) | Pharmaceutical co-crystal compositions and related methods of use | |
| US20220087999A1 (en) | C-Met Modulator Pharmaceutical Compositions | |
| US7566805B2 (en) | Modafinil compositions | |
| AU2005212229A1 (en) | Modafinil compositions | |
| WO2005089511A2 (en) | Novel pharmaceutical forms, and methods of making and using the same | |
| US7671093B2 (en) | Mixed co-crystals and pharmaceutical compositions comprising the same | |
| US7186863B2 (en) | Sertraline compositions | |
| US20040214893A1 (en) | Gabapentin compositions | |
| EP2292213A1 (en) | Compositions comprising a polymorphic form of armodafinil | |
| CN1874993B (zh) | 莫达芬尼组合物 | |
| IL199140A (en) | Modafinil preparations | |
| NZ548656A (en) | A polymorph of R-(-)-modafinil, for use in treating sleep and other disorders | |
| HK1156839A (en) | Compositions comprising a polymorphic form of armodafinil | |
| CN1980888B (zh) | 莫达芬尼组合物 | |
| MXPA06008867A (es) | Composiciones de modafinil | |
| KR20120048046A (ko) | 모다피닐 조성물 | |
| HK1083770B (en) | Pharmaceutical co-crystal of celecoxib-nicotinamide | |
| ZA200602736B (en) | Modafinil compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |